[Use of an anti-arrhythmia drug mexicord in the treatment of ventricular extrasystole]. / Primenenie antiaritmicheskogo preparata meksikorda v lechenii zheludochkovoi ekstrasistolii.

The antiarrhythmic agent mexicord (Polfa, Poland) versus ethmozine underwent a clinical trial. Meticord was found to have a marked antiarrhythmic effect and be useful in the long-term management of patients with ventricular tachyarrhythmias.